查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1511854

流式細胞技術市場規模、佔有率、趨勢分析報告：按產品、技術、最終用途、地區和細分市場進行預測，2024-2030 年

Flow Cytometry Market Size, Share & Trends Analysis Report By Product (Instruments, Software), By Technology (Bead-based, Cell-based), By Application (Industrial, Clinical), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 166 Pages | 商品交期: 2-10個工作天內

價格

流式細胞技術市場成長與趨勢：

根據Grand View Research, Inc.最新報告，預計到2030年，全球流式細胞技術市場規模將達到70.1億美元，預測期內複合年成長率為6.96%。該技術的技術進步引入了新的和改進的分析工具，例如用於照護現場(PoC) 測試的微流體流式細胞技術的開發。此外，癌症、免疫力缺乏和感染疾病病率的上升正在推動該行業的發展。此外，生物製藥、生命科學和生物技術研究活動的研發投資不斷增加，導致對流式細胞技術設備的高需求。最近的趨勢集中在開發用於 PoC 測試的可攜式微流體流式細胞技術儀設備。

微射流和流式細胞技術的結合為測量生物樣品的多種特性提供了有用的工具。例如，多種微流體和小型化檢測器的出現促進了基於微晶片的細胞計數器的開發，例如光流控細胞計數器、成像細胞計數器和電阻細胞計數器。開發具有成本效益、攜帶式且緊湊的微流體流式細胞技術設備將是有益的。這些在亞洲和非洲等新興經濟體價格實惠且可用，從而促進了 PoC 測試應用的快速成長。此外，螢光染料的改進以及桌上型細胞儀在學術研究環境中的效用不斷提高預計將推動該產業的發展。

多色流式細胞技術的發展正在加速該技術在開發新藥活動中的採用。例如，2020年1月，貝克曼庫爾特生命科學公司在歐洲推出了13色臨床流式細胞技術系統DxFLEX、CE-IVD。同樣，細胞分析和同時評估多個參數的簡便性使得此類設備廣泛用於合約研究目的。 COVID-19 大流行也刺激了技術創新，該領域新產品的推出證明了這一點。例如，2021 年 7 月，Metropolis Healthcare Ltd. 推出了 CoviRisk-TBNK，這是一種簡單的血液檢測，用於檢測住院 COVID-19 患者的風險狀態。

此測試有助於分析入住 ICU 和機械通氣的需求，減少對醫療資源的壓力。該測試是基於流式細胞技術的淋巴細胞亞群測定，並被核准作為體外診斷藥物。預計此類技術創新將在不久的將來推動產業成長。此外，流式細胞技術是列出和表徵免疫細胞的重要工具，還可以幫助識別和檢驗潛在的遺傳缺陷。該技術也用於觀察和監測幹細胞移植後患者的免疫反應，使器官移植成為產業成長的關鍵驅動力。據世界衛生組織稱，全球每年進行約5萬例幹細胞移植，這一數字可望拓展未來前景並擴大該技術的應用範圍。

另一方面，設備非常昂貴，開發中國家可能買不起技術先進的流式細胞技術設備。這些設備的成本可能高達 10 萬美元，為中小型醫院和臨床實驗室帶來了巨大的預算限制。但一些製造商，例如SONY，正在推出具有可自動執行許多流程的軟體的新設備。此類發展不僅將提高技術的可用性，還將有助於在不久的將來降低平均設備成本（低於 100,000 美元）。

流式細胞技術市場報告亮點

  • 由於技術進步、慢性病盛行率增加，設備產品領域在 2023 年佔據最大佔有率。
  • 由於對早期診斷的高需求以及對基於細胞的檢測的相關優勢的認知不斷增強，基於細胞的流式細胞技術技術將在 2023 年佔據行業主導地位。
  • 從應用來看，由於流感、HIV 和 COVID-19 等感染疾病相關活動的增加，臨床細分市場在 2023 年佔據了最大的收益佔有率。
  • 由於學術機構和研究中心的研發活動增加，學術最終用戶細分市場將在 2023 年引領市場。
  • 由於科學先進的流式細胞技術解決方案的廣泛採用、高醫療保健支出和發達的醫療基礎設施，北美在 2023 年引領市場。
  • 預計 2022 年至 2030 年亞太地區複合年成長率最快。這是由於中國和印度等新興國家製藥和生物技術行業的廣泛成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 配套市場前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 產業挑戰
  • 營商環境分析
    • PESTEL分析
    • 波特五力分析
  • COVID-19 影響分析

第 4 章流式細胞技術市場 - 細分分析（按產品），2018-2030

  • 流式細胞技術市場：產品變異分析
  • 依產品
    • 裝置
    • 試劑/耗材
    • 軟體
    • 配件
    • 服務

第 5 章流式細胞技術市場 - 按技術細分分析，2018-2030 年

  • 流式細胞技術市場：技術波動分析
  • 依技術

第6章流式細胞技術市場 - 細分分析（按應用），2018-2030

  • 流式細胞技術市場：應用變化分析
  • 按用途
    • 研究
    • 產業
    • 臨床

第 7 章流式細胞技術市場 – 細分分析（依最終用途），2018-2030

  • 流式細胞技術市場：最終用途變化分析
  • 按最終用途

第 8 章流式細胞技術市場：區域估計和趨勢分析、按產品、技術、應用和最終用途

  • 流式細胞技術市場：區域展望
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第9章 競爭格局

  • 公司簡介
    • DANAHER CORPORATION
    • BECTON, DICKINSON AND COMPANY（BD）
    • SYSMEX CORPORATION
    • AGILENT TECHNOLOGIES, INC.
    • APOGEE FLOW SYSTEMS LTD.
    • BIO-RAD LABORATORIES, INC.
    • THERMO FISHER SCIENTIFIC, INC.
    • STRATEDIGM, INC.
  • 公司分類
  • 2023 年流式細胞技術市場佔有率分析
  • 策略規劃
    • 併購
    • 夥伴關係與協作
    • 新產品發布
    • 其他

第10章結論

Product Code: GVR-1-68038-412-3

Flow Cytometry Market Growth & Trends:

The global flow cytometry market size is expected to reach USD 7.01 billion by 2030, registering a CAGR of 6.96% over the forecast period, according to a new report by Grand View Research, Inc. Technological advancements in the technique are introducing new and improved analytical tools, which include the development of microfluidic flow cytometry for Point-of-Care (PoC) testing. Furthermore, the rising prevalence of cancer, immunodeficiency disorders, and infectious diseases is driving the industry. In addition, increasing R&D investments in biopharmaceutical, life science, and biotechnology research activities have led to high demand for flow cytometry instruments. In recent years, a key focus has been on the development of portable microfluidic flow cytometry devices for PoC testing.

Microfluidics and flow cytometry together make a useful tool to measure multiple characteristics of biological samples. For instance, the easy availability of several microfluidics and miniaturized detectors have enabled the creation of microchip-based cytometers, such as optofluidic cytometer, imaging cytometer, and impedance cytometer. The development of microfluidic flow cytometry devices, which are cost-effective, portable, and compact, is beneficial. They are affordable in developing economies, such as Asia & Africa, and are enabling rapid growth in PoC testing applications. Furthermore, improvements in fluorescent dyes and the increasing utility of benchtop cytometers for academic research settings are expected to drive the industry.

Developments in multicolor flow cytometry are accelerating the adoption of the technique in novel drug development activities. For instance, in January 2020, DxFLEX, CE-IVD, a 13-colour clinical flow cytometry system was launched by Beckman Coulter Life Sciences in Europe. Similarly, easy cellular analysis by simultaneous evaluation of several parameters allows extensive use of such devices for contract research purposes. The COVID-19 pandemic also spurred innovations in the technique, as evidenced by the launch of new products in this domain. For instance, in July 2021, Metropolis Healthcare Ltd. launched CoviRisk-TBNK, a simple blood test to detect the risk status of a COVID-19 hospitalized patient.

It helps analyze patients' need for ICU facilities or ventilation and aids in the reduction of stress on healthcare resources. The test is a flow cytometry-based lymphocyte subset assay and is IVD-approved. Such innovations are anticipated to fuel industry growth in the near future. Moreover, flow cytometry is a significant tool in listing and characterizing immune cells, and is also helpful in recognizing and validating underlying genetic defects. The technique is also used to observe and monitor the immune response of patients after stem cell transplantation, and hence, organ transplantation plays an important role in boosting industry growth. According to the WHO, around 50,000 stem cell transplantations are performed globally every year, and this number is expected to grow in the near future, broadening the scope of applications for the technique.

On the other hand, instruments are highly expensive, and hence, buyers in several developing countries may not be able to afford technologically advanced flow cytometry equipment. These instruments may cost over USD 100,000 and pose significant budgetary constraints for small- & mid-sized hospitals and clinical laboratories. However, some manufacturers, such as Sony, are trying to launch newer instruments using software to automate a number of processes. Such developments would not only improve the usability of the technique but also help bring down the average instrumentation cost-under USD 100,000-in the near future.

Flow Cytometry Market Report Highlights:

  • The instrument product segment held the largest share in 2023 due to technical advancements, as well as increased prevalence of chronic conditions
  • The cell-based flow cytometry technology dominated the industry in 2023 due to the high demand for early diagnosis and rising awareness about the associated benefits of cell-based assays
  • By application, the clinical segment accounted for the largest revenue share in 2023 owing to increased activities pertaining to infectious diseases, such as influenza, HIV, and COVID-19, among others
  • The academic institutes end-user segment led the market in 2023 owing to increased R&D activities by academic institutes & research centers
  • North America was the leading region in 2023 due to the high implementation of scientifically advanced flow cytometry solutions, high healthcare expenditure, and well-established healthcare infrastructure in the region
  • Asia Pacific is expected to register the fastest CAGR from 2022 to 2030 owing to the extensive growth in the pharmaceutical and biotechnology industries in emerging economies, such as China and India

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation
    • 1.1.1 Regional Scope
    • 1.1.2 Market Definitions
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Objectives
    • 1.2.1 Objective - 1
    • 1.2.2 Objective - 2
    • 1.2.3 Objective - 3
  • 1.3 Research Methodology
  • 1.4 Information Procurement
    • 1.4.1 Purchased Database
    • 1.4.2 GVR's Internal Database
    • 1.4.3 Secondary Sources
    • 1.4.4 Primary Research
    • 1.4.5 Details Of Primary Research
  • 1.5 Information or Data Analysis
    • 1.5.1 Data Analysis Models
  • 1.6 Market Formulation & Validation
  • 1.7 Model Details
    • 1.7.1 Commodity Flow Analysis
      • 1.7.1.1 Approach 1: Commodity Flow Approach
      • 1.7.1.2 Approach 2: Country wise market estimation using bottom-up approach
  • 1.8 List of Secondary Sources
  • 1.9 List of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Product and Technology Segment Snapshot
  • 2.3 Application and End-use Segment Snapshot
  • 2.4 Competitive Landscape Snapshot

Chapter 3 Market Variables, Trends, and Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
      • 3.2.1.1 Growing prevalence of chronic and infectious diseases
      • 3.2.1.2 High R&D investments in biotechnology, clinical, and life science research
      • 3.2.1.3 Technological advancements in flow cytometry instruments and reagents
      • 3.2.1.4 Increasing demand for point-of-care diagnostics
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 High Cost Of Instruments
    • 3.2.3 Industry Challenges
      • 3.2.3.1 Low Cell Throughput Rate
  • 3.3 Business Environment Analysis
    • 3.3.1 Pestel Analysis
    • 3.3.2 Porter's Five Forces Analysis
  • 3.4 COVID-19 Impact Analysis

Chapter 4 Flow Cytometry Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)

  • 4.1 Flow Cytometry Market: Product Movement Analysis
  • 4.2 Flow Cytometry Market Estimates & Forecast by Product (USD Million)
    • 4.2.1 Instruments
      • 4.2.1.1 Cell Analyzers
      • 4.2.1.2 Cell Sorters
    • 4.2.2 Reagents & Consumables
    • 4.2.3 Software
    • 4.2.4 Accessories
    • 4.2.5 Services

Chapter 5 Flow Cytometry Market - Segment Analysis, by Technology, 2018 - 2030 (USD Million)

  • 5.1 Flow Cytometry Market: Technology Movement Analysis
  • 5.2 Flow Cytometry Market Estimates & Forecast by Technology (USD Million)
    • 5.2.1 Cell-Based
    • 5.2.2 Bead-Based

Chapter 6 Flow Cytometry Market - Segment Analysis, by Application, 2018 - 2030 (USD Million)

  • 6.1 Flow Cytometry Market: Application Movement Analysis
  • 6.2 Flow Cytometry Market Estimates & Forecast by Application (USD Million)
    • 6.2.1 Research
      • 6.2.1.1 Pharmaceutical
      • 6.2.1.1.1 Drug Discovery
      • 6.2.1.1.2 Stem Cell
      • 6.2.1.1.3 In Vitro Toxicity
      • 6.2.1.2 Apoptosis
      • 6.2.1.3 Cell Sorting
      • 6.2.1.4 Cell Cycle Analysis
      • 6.2.1.5 Immunology
      • 6.2.1.6 Cell Viability
    • 6.2.2 Industrial
    • 6.2.3 Clinical
      • 6.2.3.1 Cancer
      • 6.2.3.2 Organ Transplantation
      • 6.2.3.3 Immunodeficiency
      • 6.2.3.4 Hematology
      • 6.2.3.5 Autoimmune Disorders

Chapter 7 Flow Cytometry Market - Segment Analysis, by End Use, 2018 - 2030 (USD Million)

  • 7.1 Flow Cytometry Market: End-use Movement Analysis
  • 7.2 Flow Cytometry Market Estimates & Forecast by End Use (USD Million)
    • 7.2.1 Commercial Organizations
      • 7.2.1.1 Biotechnology Companies
      • 7.2.1.2 Pharmaceutical Companies
      • 7.2.1.3 Cros
    • 7.2.2 Hospitals
    • 7.2.3 Academic Institutes
    • 7.2.4 Clinical Testing Labs

Chapter 8 Flow Cytometry Market: Regional Estimates and Trend Analysis, By Product, Technology, Application, and End Use

  • 8.1 Flow Cytometry Market: Regional Outlook
  • 8.2 North America
    • 8.2.1 North America Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 Key Country Dynamics
      • 8.2.2.2 U.S. Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.2.2.3 Competitive/Market Scenario
      • 8.2.2.4 Regulatory Framework
      • 8.2.2.5 Reimbursement Scenario
    • 8.2.3 Canada
      • 8.2.3.1 Key Country Dynamics
      • 8.2.3.2 Canada flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
      • 8.2.3.3 Competitive/Market Scenario
      • 8.2.3.4 Regulatory Framework
      • 8.2.3.5 Reimbursement Scenario
  • 8.3 Europe
    • 8.3.1 Europe Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2 UK
      • 8.3.2.1 Key Country Dynamics
      • 8.3.2.2 UK Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.2.3 Competitive/Market Scenario
      • 8.3.2.4 Regulatory Framework
      • 8.3.2.5 Reimbursement Scenario
    • 8.3.3 Germany
      • 8.3.3.1 Key Country Dynamics
      • 8.3.3.2 Germany Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.3.3 Competitive/Market Scenario
      • 8.3.3.4 Regulatory Framework
      • 8.3.3.5 Reimbursement Scenario
    • 8.3.4 France
      • 8.3.4.1 Key Country Dynamics
      • 8.3.4.2 France Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.4.3 Competitive Scenario
      • 8.3.4.4 Regulatory Framework
      • 8.3.4.5 Reimbursement Scenario
    • 8.3.5 Italy
      • 8.3.5.1 Key Country Dynamics
      • 8.3.5.2 Italy Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.5.3 Competitive/Market Scenario
      • 8.3.5.4 Regulatory Framework
      • 8.3.5.5 Reimbursement Scenario
    • 8.3.6 Spain
      • 8.3.6.1 Key Country Dynamics
      • 8.3.6.2 Spain Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.6.3 Competitive/Market Scenario
      • 8.3.6.4 Regulatory Framework
      • 8.3.6.5 Reimbursement Scenario
    • 8.3.7 Denmark
      • 8.3.7.1 Key Country Dynamics
      • 8.3.7.2 Denmark Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.7.3 Competitive/Market Scenario
      • 8.3.7.4 Regulatory Framework
      • 8.3.7.5 Reimbursement Scenario
    • 8.3.8 Sweden
      • 8.3.8.1 Key Country Dynamics
      • 8.3.8.2 Sweden Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.8.3 Competitive/Market Scenario
      • 8.3.8.4 Regulatory Framework
    • 8.3.9 Norway
      • 8.3.9.1 Key Country Dynamics
      • 8.3.9.2 Norway Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.9.3 Competitive/Market Scenario
      • 8.3.9.4 Regulatory Framework
      • 8.3.9.5 Reimbursement Scenario
    • 8.3.10 Rest Of Europe Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2 Japan
      • 8.4.2.1 Key Country Dynamics
      • 8.4.2.2 Japan Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.2.3 Competitive/Market Scenario
      • 8.4.2.4 Regulatory Framework
      • 8.4.2.5 Reimbursement Scenario
    • 8.4.3 China
      • 8.4.3.1 Key Country Dynamics
      • 8.4.3.2 China Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.3.3 Competitive/Market Scenario
      • 8.4.3.4 Regulatory Framework
      • 8.4.3.5 Reimbursement Scenario
    • 8.4.4 India
      • 8.4.4.1 Key Country Dynamics
      • 8.4.4.2 India Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.4.3 Competitive/Market Scenario
      • 8.4.4.4 Regulatory Framework
      • 8.4.4.5 Reimbursement Scenario
    • 8.4.5 Australia
      • 8.4.5.1 Key Country Dynamics
      • 8.4.5.2 Australia Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.5.3 Competitive/Market Scenario
      • 8.4.5.4 Regulatory Framework
      • 8.4.5.5 Reimbursement Scenario
    • 8.4.6 Thailand
      • 8.4.6.1 Key Country Dynamics
      • 8.4.6.2 Thailand Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.6.3 Competitive/Market Scenario
      • 8.4.6.4 Regulatory Framework
      • 8.4.6.5 Reimbursement Scenario
    • 8.4.7 South Korea
      • 8.4.7.1 Key Country Dynamics
      • 8.4.7.2 South Korea Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.7.3 Competitive/Market Scenario
      • 8.4.7.4 Regulatory Framework
      • 8.4.7.5 Reimbursement Scenario
    • 8.4.8 Singapore
      • 8.4.8.1 Key Country Dynamics
      • 8.4.8.2 Singapore Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.8.3 Competitive Scenario
      • 8.4.8.4 Regulatory Framework
      • 8.4.8.5 Reimbursement Scenario
    • 8.4.9 Rest Of Asia Pacific Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America Flow Cytometry Market Estimates And Forecasts, 2018 - 2030, (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Key Country Dynamics
      • 8.5.2.2 Brazil Flow Cytometry Market Estimates And Forecasts, 2018 - 2030, (USD Million)
      • 8.5.2.3 Competitive/Market Scenario
      • 8.5.2.4 Regulatory Framework
      • 8.5.2.5 Reimbursement Scenario
    • 8.5.3 Mexico
      • 8.5.3.1 Key Country Dynamics
      • 8.5.3.2 Mexico Flow Cytometry Market Estimates And Forecasts, 2018 - 2030, (USD Million)
      • 8.5.3.3 Competitive/Market Scenario
      • 8.5.3.4 Regulatory Framework
      • 8.5.3.5 Reimbursement Scenario
    • 8.5.4 Argentina
      • 8.5.4.1 Key Country Dynamics
      • 8.5.4.2 Argentina Flow Cytometry Market Estimates And Forecasts, 2018 - 2030, (USD Million)
      • 8.5.4.3 Competitive/Market Scenario
      • 8.5.4.4 Regulatory Framework
      • 8.5.4.5 Rest of Latin America Flow Cytometry Market Estimates And Forecasts, 2018 - 2030, (USD Million)
  • 8.6 MEA
    • 8.6.1 MEA Flow Cytometry Market Estimates And Forecasts, 2018 - 2030, (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 Key Country Dynamics
      • 8.6.2.2 South Africa Flow Cytometry Market Estimates and Forecasts, 2018 - 2030, (USD Million)
      • 8.6.2.3 Competitive Scenario
      • 8.6.2.4 Regulatory Framework
      • 8.6.2.5 Reimbursement Scenario
    • 8.6.3 Saudi Arabia
      • 8.6.3.1 Key Country Dynamics
      • 8.6.3.2 Saudi Arabia Flow Cytometry Market Estimates and Forecasts, 2018 - 2030, (USD Million)
      • 8.6.3.3 Competitive Scenario
      • 8.6.3.4 Regulatory Framework
      • 8.6.3.5 Reimbursement Scenario
    • 8.6.4 UAE
      • 8.6.4.1 Key Country Dynamics
      • 8.6.4.2 UAE Flow Cytometry Market Estimates and Forecasts, 2018 - 2030, (USD Million)
      • 8.6.4.3 Competitive Scenario
      • 8.6.4.4 Regulatory Framework
      • 8.6.4.5 Reimbursement Scenario
    • 8.6.5 Kuwait
      • 8.6.5.1 Key Country Dynamics
      • 8.6.5.2 Kuwait Flow Cytometry Market Estimates and Forecasts, 2018 - 2030, (USD Million)
      • 8.6.5.3 Competitive Scenario
      • 8.6.5.4 Regulatory Framework
      • 8.6.5.5 Reimbursement Scenario
    • 8.6.6 Rest Of Mea Flow Cytometry Market Estimates And Forecasts, 2018-2030 (USD Million)

Chapter 9 Competitive Landscape

  • 9.1 Company Profiles
    • 9.7.1 DANAHER CORPORATION
      • 9.7.1.1 Company overview
      • 9.7.1.2 Beckman Coulter, Inc.
      • 9.7.1.2.1 Company Overview
      • 9.7.1.3 Cytiva
      • 9.7.1.3.1 Company Overview
      • 9.7.1.4 Financial performance
      • 9.7.1.5 Product benchmarking
      • 9.7.1.6 Strategic initiatives
    • 9.7.2 BECTON, DICKINSON AND COMPANY (BD)
      • 9.7.2.1 Company overview
      • 9.7.2.2 Financial performance
      • 9.7.2.3 Product benchmarking
      • 9.7.2.4 Strategic initiatives
    • 9.7.3 SYSMEX CORPORATION
      • 9.7.3.1 Company overview
      • 9.7.3.2 Financial performance
      • 9.7.3.3 Product benchmarking
      • 9.7.3.4 Strategic initiatives
    • 9.7.4 AGILENT TECHNOLOGIES, INC.
      • 9.7.4.1 Company overview
      • 9.7.4.2 Financial performance
      • 9.7.4.3 Product benchmarking
      • 9.7.4.4 Strategic initiatives
    • 9.7.5 APOGEE FLOW SYSTEMS LTD.
      • 9.7.5.1 Company overview
      • 9.7.5.2 Product benchmarking
      • 9.7.5.3 Strategic initiatives
    • 9.7.6 BIO-RAD LABORATORIES, INC.
      • 9.7.6.1 Company overview
      • 9.7.6.2 Financial performance
      • 9.7.6.3 Product benchmarking
      • 9.7.6.4 Strategic initiatives
    • 9.7.7 THERMO FISHER SCIENTIFIC, INC.
      • 9.7.7.1 Company overview
      • 9.7.7.2 Financial performance
      • 9.7.7.3 Product benchmarking
      • 9.7.7.4 Strategic initiatives
    • 9.7.8 STRATEDIGM, INC.
      • 9.7.8.1 Company overview
      • 9.7.8.2 Product benchmarking
  • 9.2 Company Categorization
  • 9.3 Flow cytometry Market Share Analysis, 2023
  • 9.4 Strategy Mapping
    • 9.4.1 Mergers & Acquisitions
    • 9.4.2 Partnerships And Collaborations
    • 9.4.3 New Product Launch
    • 9.4.4 Others

Chapter 10 Conclusion

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Regulatory status and recommended validation strategy for flow cytometry assays
  • Table 3 CPT codes for flow cytometry reimbursement
  • Table 4 Global flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 5 Global flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 6 Global flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 7 Global flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 8 Global flow cytometry market, by region, 2018 - 2030 (USD Million)
  • Table 9 North America flow cytometry market, by country, 2018 - 2030 (USD Million)
  • Table 10 North America flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 11 North America flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 12 North America flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 13 North America flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 14 U.S. Flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 15 U.S. Flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 16 U.S. Flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 17 U.S. Flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 18 Canada flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 19 Canada flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 20 Canada flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 21 Canada flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 22 Europe flow cytometry market, by country, 2018 - 2030 (USD Million)
  • Table 23 Europe flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 24 Europe flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 25 Europe flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 26 Europe flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 27 Germany flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 28 Germany flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 29 Germany flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 30 Germany flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 31 U.K. flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 32 U.K. flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 33 U.K. flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 34 U.K. flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 35 France flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 36 France flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 37 France flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 38 France flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 39 Italy flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 40 Italy flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 41 Italy flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 42 Italy flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 43 Spain flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 44 Spain flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 45 Spain flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 46 Spain flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 47 Denmark flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 48 Denmark flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 49 Denmark flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 50 Denmark flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 51 Sweden flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 52 Sweden flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 53 Sweden flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 54 Sweden flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 55 Norway flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 56 Norway flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 57 Norway flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 58 Norway flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 59 Asia pacific flow cytometry market, by country, 2018 - 2030 (USD Million)
  • Table 60 Asia pacific flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 61 Asia pacific flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 62 Asia pacific flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 63 Asia pacific flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 64 China flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 65 China flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 66 China flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 67 China flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 68 India flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 69 India flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 70 India flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 71 India flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 72 Japan flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 73 Japan flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 74 Japan flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 75 Japan flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 76 South Korea flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 77 South Korea flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 78 South Korea flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 79 South Korea flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 80 Australia flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 81 Australia flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 82 Australia flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 83 Australia flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 84 Thailand flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 85 Thailand flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 86 Thailand flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 87 Thailand flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 88 Singapore flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 89 Singapore flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 90 Singapore flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 91 Singapore flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 92 Latin America flow cytometry market, by country, 2018 - 2030 (USD Million)
  • Table 93 Latin America flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 94 Latin America flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 95 Latin America flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 96 Latin America flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 97 Brazil flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 98 Brazil flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 99 Brazil flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 100 Brazil flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 101 Mexico flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 102 Mexico flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 103 Mexico flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 104 Mexico flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 105 Argentina flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 106 Argentina flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 107 Argentina flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 108 Argentina flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 109 Middle east & Africa flow cytometry market, by country, 2018 - 2030 (USD Million)
  • Table 110 Middle east & Africa flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 111 Middle east & Africa flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 112 Middle east & Africa flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 113 Middle east & Africa flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 114 South Africa flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 115 South Africa flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 116 South Africa flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 117 South Africa flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 118 Saudi Arabia flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 119 Saudi Arabia flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 120 Saudi Arabia flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 121 Saudi Arabia flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 122 UAE flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 123 UAE flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 124 UAE flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 125 UAE flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 126 Kuwait flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 127 Kuwait flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 128 Kuwait flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 129 Kuwait flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 130 Company Market Share Analysis, 2023

List of Figures

  • Fig. 1 Flow cytometry market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Value chain based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Product and technology segment snapshot
  • Fig. 10 Application and end-use segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Life science tools market value, 2023 (USD Billion)
  • Fig. 13 Market dynamics
  • Fig. 14 PESTEL analysis
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 Flow cytometry market: Product outlook and key takeaways
  • Fig. 17 Flow cytometry market: Product movement analysis
  • Fig. 18 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Cell analyzers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Cell sorters market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Reagents & consumables market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 22 Software market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 23 Accessories market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 24 Services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 25 Flow cytometry market: Technology outlook and key takeaways
  • Fig. 26 Flow cytometry market: Technology movement analysis
  • Fig. 27 Cell-based market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Bead-based market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Flow cytometry market: Application outlook and key takeaways
  • Fig. 30 Flow cytometry market: Application movement analysis
  • Fig. 31 Research market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Pharmaceutical market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Drug discovery market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Stem cell market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 In vitro toxicity market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Apoptosis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Cell sorting market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Cell cycle analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Immunology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Cell viability market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Industrial market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Clinical market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Organ transplantation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Immunodeficiency market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Autoimmune disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Flow cytometry market: End-use outlook and key takeaways
  • Fig. 49 Flow cytometry market: End-use movement analysis
  • Fig. 50 Commercial organizations market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Biotechnology companies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Pharmaceutical companies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 CROs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Academic institutes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Clinical testing labs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Flow cytometry market revenue, by region, 2023 & 2030 (USD Million)
  • Fig. 58 Regional marketplace: Key takeaways
  • Fig. 59 Regional marketplace: Key takeaways
  • Fig. 60 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 U.S. flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Canada flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Europe flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 UK flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Germany flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 France flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Italy flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Spain flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Denmark flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Sweden flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Norway flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Rest of Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Asia Pacific flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Japan flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 China flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 India flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Australia flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Thailand flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 South Korea flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Singapore flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 98 Rest of Asia Pacific flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 99 Latin America flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 100 Key country dynamics
  • Fig. 101 Brazil flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 102 Key country dynamics
  • Fig. 103 Mexico flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 104 Key country dynamics
  • Fig. 105 Argentina flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 106 Rest of Latin America flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 107 MEA flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 108 Key country dynamics
  • Fig. 109 South Africa flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 110 Key country dynamics
  • Fig. 111 Saudi Arabia flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 112 Key country dynamics
  • Fig. 113 UAE flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 114 Key country dynamics
  • Fig. 115 Kuwait flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 116 Rest of MEA flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 117 Key company categorization
  • Fig. 118 Flow cytometry market share analysis, 2023
  • Fig. 119 Strategy mapping